FDA approves Eli Lilly drug to cut death, hospitalization risk in all heart patients – Reuters

Feb 24 (Reuters) – The U.S. Food and Drug Administration said on Thursday it had approved Eli Lilly (LLY.N) and partner Boehringer Ingelheim’s drug, Jardiance, for expanded use in reducing the risk o… [+871 chars]

Leave a Reply

Your email address will not be published. Required fields are marked *